title: Critical role of hyperthermic intraperitoneal chemoperfusion in the treatment of a patient with Pseudomyxoma peritonei.
abstract: The role of hyperthermic intraperitoneal chemoperfusion (HIPEC) in the treatment of Pseudomyxoma peritonei is debated by clinicians. We report the case of a patient who had multiple episodes of short-interval disease recurrence following debulking surgery, and only achieved long-term remission with the addition of HIPEC. A review of the relevant literature is presented.
authors.affiliation: Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. coleka@mercyme.com
authors.forename: Karin L
authors.initials: KL
authors.lastname: Cole
authors.forename: Haroon A
authors.initials: HA
authors.lastname: Choudry
authors.forename: Heather L
authors.initials: HL
authors.lastname: Jones
authors.forename: Pamela P
authors.initials: PP
authors.lastname: Goodell
authors.forename: David L
authors.initials: DL
authors.lastname: Bartlett
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D007263:Infusions, Parenteral; D010534:Peritoneal Neoplasms / Q000628:therapy*; D011553:Pseudomyxoma Peritonei / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents